Medical Health & Life Science Research News

Report explores the hemostats market worth USD 4.5 billion by 2024 | CAGR 6.5%

Report explores the hemostats market worth USD 4.5 billion by 2024 | CAGR 6.5%

The report "Global Hemostats Market" is segmented into based on product type, indication, end-user and geography.

- Advertising -

Global Hemostats Market, By Product Type (Thrombin Based, Combination, Oxidized Regenerated Cellulose Based, Gelatin Based, Collagen Based Hemostat), By Indication (Wound Closure, Surgery), By End-User (Hospitals, Clinics, Ambulatory Centers, Community Healthcare, Others), By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Trends and Forecast to 2024

The global hemostats market has accounted to USD 2.7 billion in 2016, and is expected to reach USD 4.5 billion by 2024, growing at a CAGR of 6.5% in the forecast period 2017 to 2024.

Ask for Sample Report Visit @ databridgemarketresearch.com/reque…nds-forecast-2024

Global Hemostats Market - Segmentation:

The global hemostats market is segmented based on product type, indication, end-user and geography.

On the basis of product the market is segmented into into 5 product type’s thrombin based hemostats, combination agents hemostats, oxidized regeneration cellulose based hemostats, gelatin based hemostats and collagen based segments.

The Global Hemostats Market is also segmented based on indications type into wound closure and surgery.

- Advertising -

Based on end-users the market is segmented into hospitals, clinics, ambulatory centers, community healthcare and others.

Inquire report @ databridgemarketresearch.com/inqui…nds-forecast-2024

Global Hemostats Market - Geographical Segmentation

Based on geography the global hemostats devices market covers data points for 52 countries across multiple geographies namely North & South America, Europe, Asia-Pacific and, Middle East & Africa. North America dominates the market in terms of consumption of hemostats followed by Europe and APAC.

. In terms of revenue North America holds 57.7% of the market in 2015, followed by Europe with 20.1% and APAC with 14.2%. APAC is expected to be the fastest growing market in the forecasted years owing to increasing number of surgeries in this region among other growth opportunities.

Global Hemostats Market - Competitive Landscape:

The Global Hemostats market is highly competitive and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. Some of the recent developments in the hemostats market are: April 2015, Ethicon’s fibrin sealant patch received food and drug administration approval for extended surgical indications; April 2016, 3-D Matrix Europe subsidiary entered partnership with Chile based M.

Kaplan Y CIA LTDA. for sistribution rights of PuraStat hemostat of 3-D Matrix in Chile. The report includes market shares of global hemostats market for U.S., Canada, Brazil, Mexico, Germany, France, U.K., China, India, Japan, North America, South America, Europe, Asia-Pacific and Middle East and Africa.

Some of the major players operating in this market are Pfizer, C.R. Bard, Baxter, Vascular Solutions, Inc., B.Braun Melsungen, 3-D Matrix, Ltd., Resorba Medical GmbH (A Advanced Medical Solutions Group plc Company), Anika Therapeutics, Inc., Arch Therapeutics Inc., Biom’Up SAS, CryoLife, Inc., Gamma Therapeutics, Inc., Hemostasis, LLC, Medtrade Products Ltd., Integra Lifesciences Corporation, Medline Industries, Inc., Hemotec Medical GmbH, Stryker, Hemostasis, LLC., CSL Behring, Mallinckrodt plc.

and Equimedical, B.V. among other companies.

Browse Full Report Visit @ databridgemarketresearch.com/repor…nds-forecast-2024

Table of Content:

  1. INTRODUCTION
  2. RESEARCH METHODOLOGY
  3. MARKET LANDSCAPE SUMMARY
  4. PREMIUM INSIGHTS
  5. HEMOSTATS MARKET, BY PRODUCT TYPE
  6. HEMOSTATS MARKET,  BY INDICATION
  7. HEMOSTATS MARKET,  BY END-USER
  8. HEMOSTATS MARKET, BY GEOGRAPHY

      8.1. COUNTRYWISE HEMOSTATS MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)

      8.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

  1. HEMOSTATS MARKET: COMPETITIVE LANDSCAPE

      9.1. GLOBAL HEMOSTATS MARKET: COMPANY SHARE ANALYSIS

      9.2. U.S. HEMOSTATS MARKET: COMPANY SHARE ANALYSIS

      9.3. EUROPE HEMOSTATS MARKET: COMPANY SHARE ANALYSIS

      9.4. ASIA-PACIFIC HEMOSTATS MARKET: COMPANY SHARE ANALYSIS

      9.5. MERGERS & ACQUISITIONS

      9.6. NEW PRODUCT DEVELOPMENT & APPROVALS

      9.7. EXPANSIONS

      9.8. REGULATORY CHANGES

      9.9. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS

  1. HEMOSTATS MARKET, COMPANY PROFILES

      10.1. ETHICON, INC. (A JOHNSON AND JOHNSON COMPANY)

      10.2. PFIZER

      10.3. C.R. BARD

      10.4. BAXTER

      10.5. VASCULAR SOLUTIONS, INC.

      10.6. B.BRAUN MELSUNGEN

      10.7. 3-D MATRIX, LTD

      10.8. RESORBA MEDICAL GMBH (A ADVANCED MEDICAL SOLUTIONS GROUP PLC COMPANY)

      10.9. ANIKA THERAPEUTICS, INC.

      10.10. ARCH THERAPEUTICS INC.

      10.11. BIOM’UP SAS

      10.12. CRYOLIFE, INC.

      10.13. GAMMA THERAPEUTICS, INC.

      10.14. HEMOSTASIS, LLC

      10.15. MEDTRADE PRODUCTS LTD.

      10.16. INTEGRA LIFESCIENCES CORPORATION

      10.17. MEDLINE INDUSTRIES, INC.

      10.18. HEMOTEC MEDICAL GMBH

               10.18.1. OVERVIEW

               10.18.2. SWOT ANALYSIS

               10.18.3. PRODUCT PORTFOLIO

               10.18.4. REVENUE ANALYSIS

               10.18.5. ANALYSTS VIEW

      10.19. STRYKER

                10.19.1. OVERVIEW

                10.19.2. SWOT ANALYSIS

                10.19.3. PRODUCT PORTFOLIO

                10.19.4. REVENUE ANALYSIS

               10.19.5. ANALYSTS VIEW

      10.20. HEMOSTASIS, LLC.

               10.20.1. OVERVIEW

               10.20.2. SWOT ANALYSIS

                10.20.3. PRODUCT PORTFOLIO

                10.20.4. REVENUE ANALYSIS

                10.20.5. ANALYSTS VIEW

      10.21. CSL BEHRING

               10.21.1. OVERVIEW

               10.21.2. SWOT ANALYSIS

               10.21.3. PRODUCT PORTFOLIO

               10.21.4. REVENUE ANALYSIS

               10.21.5. ANALYSTS VIEW

      10.22. MALLINCKRODT PLC.

               10.22.1. OVERVIEW

               10.22.2. SWOT ANALYSIS

               10.22.3. PRODUCT PORTFOLIO

               10.22.4. REVENUE ANALYSIS

               10.22.5. ANALYSTS VIEW

      10.23. EQUIMEDICAL, B.V.

               10.23.1. OVERVIEW

               10.23.2. SWOT ANALYSIS

               10.23.3. PRODUCT PORTFOLIO

               10.23.4. REVENUE ANALYSIS

               10.23.5. ANALYSTS VIEW

News From

Data Bridge Market ResearchData Bridge Market Research
Category: Market Research Publishers and RetailersCompany profile: Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data bridge is an aftermath of sheer wi ...